Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults

Clinical trial NCT02333591 · COMPLETED

Trial details

NCT number: NCT02333591
Sponsor: Mette Zander
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Coronary Microvascular Dysfunction

Start date: 2016-07-01
Primary completion: 2018-06-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.